T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
ANI Pharmaceuticals
ANIP
$1.85B
| $1.04M | ﹤0.01% |
13,483
+2,930
| +28% | +$229K |
|
2127
Scholastic
SCHL
$773M
| $1.03M | ﹤0.01% |
26,471
+3,040
| +13% | +$105K |
|
2128
Ameresco
AMRC
$981M
| $1.03M | ﹤0.01% |
40,504
+4,279
| +12% | +$128K |
|
2129
Empire State Realty Trust
ESRT
$1.02B
| $1.03M | ﹤0.01% |
197,999
+29,332
| +17% | +$176K |
|
2130
TriMas Corp
TRS
$1.4B
| $1.03M | ﹤0.01% |
28,604
-2,417
| -8% | -$86.7K |
|
|
NESR
2131
National Energy Services Reunited Corp
NESR
$2.48B
| $1.03M | ﹤0.01% |
47,862
+13,055
| +38% | +$272K |
|
2132
Consensus Cloud Solutions
CCSI
$682M
| $1.02M | ﹤0.01% |
43,115
+2,368
| +6% | +$60.9K |
|
2133
PACS Group
PACS
$7.34B
| $1.02M | ﹤0.01% |
31,859
+6,675
| +27% | +$245K |
|
2134
CRA International
CRAI
$1.25B
| $1.02M | ﹤0.01% |
6,306
+1,360
| +27% | +$245K |
|
|
DEA
2135
Easterly Government Properties
DEA
$1.18B
| $1.02M | ﹤0.01% |
47,419
+6,129
| +15% | +$140K |
|
|
WSR
2136
DELISTED
Whitestone REIT
WSR
| $1.02M | ﹤0.01% |
62,924
+7,530
| +14% | +$113K |
|
2137
Trupanion
TRUP
$1.13B
| $1.01M | ﹤0.01% |
39,509
+5,852
| +17% | +$175K |
|
2138
AvePoint
AVPT
$2.75B
| $1.01M | ﹤0.01% |
106,265
+23,404
| +28% | +$264K |
|
2139
F&G Annuities & Life
FG
$3.97B
| $1.01M | ﹤0.01% |
39,846
+13,121
| +49% | +$342K |
|
2140
Revolution Medicines Inc Warrant
RVMDW
$93.5M
| $1.01M | ﹤0.01% |
579,550
-16,384
| -3% | -$31.7K |
|
2141
Vertex
VERX
$2.2B
| $1.01M | ﹤0.01% |
84,589
+13,947
| +20% | +$217K |
|
2142
United States Lime & Minerals
USLM
$3.14B
| $1M | ﹤0.01% |
7,693
+1,211
| +19% | +$146K |
|
2143
Under Armour
UAA
$3B
| $1M | ﹤0.01% |
169,637
+21,389
| +14% | +$139K |
|
2144
Navient
NAVI
$829M
| $998K | ﹤0.01% |
121,938
+24,866
| +26% | +$246K |
|
2145
VanEck Semiconductor ETF
SMH
$61.1B
| $997K | ﹤0.01% |
2,600
| – | – |
|
2146
Bank First Corp
BFC
$1.69B
| $992K | ﹤0.01% |
7,338
+2,062
| +39% | +$281K |
|
2147
MVB Financial
MVBF
$400M
| $992K | ﹤0.01% |
39,945
+3,792
| +10% | +$102K |
|
2148
Avanos Medical
AVNS
| $989K | ﹤0.01% |
70,545
+8,014
| +13% | +$108K |
|
2149
Vitesse Energy
VTS
$639M
| $988K | ﹤0.01% |
54,395
+3,655
| +7% | +$73.6K |
|
|
EHAB
2150
DELISTED
Enhabit
EHAB
| $986K | ﹤0.01% |
69,915
+11,359
| +19% | +$136K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.